The First Trust NYSE Arca Biotechnology Index Fund ETF (FBT) experienced unusually high trading volume on Wednesday, with over 398,000 shares traded compared to a three-month average of about 28,000. The ETF saw a gain of approximately 2.5% for the day.
Key components driving this activity included Moderna, which rose by around 10.5% with over 10.6 million shares exchanged, and Gilead Sciences, which increased by about 2.8% on volume exceeding 2.2 million shares. In contrast, Exact Sciences saw a modest increase of just 0.1% during the session.
